INTRACELLULAR IONIC VARIATIONS IN THE APOPTOTIC DEATH OF L-CELLS BY INHIBITORS OF CELL-CYCLE PROGRESSION

被引:148
作者
BARBIERO, G
DURANTI, F
BONELLI, G
AMENTA, JS
BACCINO, FM
机构
[1] UNIV PITTSBURGH, SCH MED, DEPT PATHOL, PITTSBURGH, PA 15260 USA
[2] CNR, CTR IMMUNOGENET & ONCOL SPERIMENTALE, I-10126 TURIN, ITALY
关键词
D O I
10.1006/excr.1995.1104
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Treatment with VP-16 (1-50 mu M) Or excess thymidine (5 mM) caused a block of L cells at different steps in their progression through the replicative cycle. The arrest was followed by an asynchronous process of cell death that conformed to criteria for apoptosis. Careful monitoring of this process in the whole cell population by flow cytometry showed a virtual absence of necrosis, an increase in side light scattering, followed by the occurrence of a population with subdiploid DNA fluorescence as well as reduced forward and side light scattering. The development of apoptosis required sufficient time and adequate ion gradients in the cells. By the combined use of flow cytometry and fluorescence microscopy data were obtained suggesting that (i) intracellular free Ca2+ and pH and/or their drug-induced alterations had to be adequately controlled for the apoptotic process to evolve; (ii) mitochondria were compromised earlier than the plasma membrane or lysosomes; and (iii) K+ extrusion possibly played a role in the final loss of cell volume. Interfering with the control of ion gradients and/or their changes in drug-treated cells resulted in cell death by necrosis. (C) 1995 Academic Press, Inc.
引用
收藏
页码:410 / 418
页数:9
相关论文
共 50 条
[1]
ALNEMRI ES, 1990, J BIOL CHEM, V265, P17323
[2]
AMENTA JS, 1993, IN VITRO CELL DEV-AN, V29A, P855
[3]
AMENTA JS, 1989, RBC-CELL BIOL REV, V21, P401
[4]
ARENDS MJ, 1990, AM J PATHOL, V136, P593
[5]
ARENDS MJ, 1994, AM J PATHOL, V144, P1045
[6]
BARRY MA, 1993, CANCER RES, V53, P2349
[7]
ENDONUCLEASE ACTIVATION DURING APOPTOSIS - THE ROLE OF CYTOSOLIC CA2+ AND PH [J].
BARRY, MA ;
EASTMAN, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :782-789
[8]
BELLOMO G, 1992, CANCER RES, V52, P1342
[9]
BONELLI G, 1993, GENERAL PATHOLOGY PA, P105
[10]
BORIN M, 1990, J BIOL CHEM, V265, P19543